Tower Research Capital LLC (Trc) Arca Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.71 - $4.0 $4,670 - $10,924	-2,731 Reduced 88.81%	344 $1,000
Q1 2024 May 15, 2024	BUY	$1.58 - $1.78 $82 - $92	52 Added 1.72%	3,075 $5,000
Q4 2023 Feb 13, 2024	SELL	$1.7 - $2.05 $1,135 - $1,369	-668 Reduced 18.1%	3,023 $5,000
Q3 2023 Nov 14, 2023	BUY	$2.01 - $2.07 $2,510 - $2,585	1,249 Added 51.15%	3,691 $7,000
Q2 2023 Aug 14, 2023	SELL	$1.94 - $2.11 $1,065 - $1,158	-549 Reduced 18.36%	2,442 $4,000
Q1 2023 May 09, 2023	BUY	$1.99 - $2.55 $3,022 - $3,873	1,519 Added 103.19%	2,991 $6,000
Q4 2022 Feb 10, 2023	BUY	$1.86 - $25.8 $1,767 - $24,510	950 Added 181.99%	1,472 $3,000
Q3 2022 Nov 10, 2022	BUY	$2.13 - $25.68 $1,111 - $13,404	522 New	522 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.2 - $2.53 $10,892 - $12,526	-4,951 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.77 - $2.49 $4,718 - $6,638	2,666 Added 116.67%	4,951 $11,000
Q4 2021 Feb 14, 2022	SELL	$2.15 - $2.97 $120 - $166	-56 Reduced 2.39%	2,285 $5,000
Q3 2021 Nov 15, 2021	BUY	$2.77 - $3.74 $6,293 - $8,497	2,272 Added 3292.75%	2,341 $7,000
Q2 2021 Aug 16, 2021	SELL	$3.06 - $3.9 $47,708 - $60,804	-15,591 Reduced 99.56%	69 $0
Q1 2021 May 17, 2021	BUY	$3.48 - $5.3 $54,496 - $82,998	15,660 New	15,660 $57,000
Q4 2020 Feb 16, 2021	SELL	$3.74 - $5.18 $594 - $823	-159 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.07 - $7.99 $647 - $1,270	159 New	159 $1,000
Q1 2020 May 15, 2020	SELL	$2.32 - $6.42 $2 - $6	-1 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$4.95 - $5.96 $4 - $5	1 New	1 $0

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.